BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34396578)

  • 1. Evidence for glutamine synthetase function in mouse spinal cord oligodendrocytes.
    Ben Haim L; Schirmer L; Zulji A; Sabeur K; Tiret B; Ribon M; Chang S; Lamers WH; Boillée S; Chaumeil MM; Rowitch DH
    Glia; 2021 Dec; 69(12):2812-2827. PubMed ID: 34396578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine synthetase activity and expression are not affected by the development of motor neuronopathy in the G93A SOD-1/ALS mouse.
    Fray AE; Dempster S; Williams RE; Cookson MR; Shaw PJ
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):131-6. PubMed ID: 11597773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord.
    Yoshikawa M; Ishikawa C; Li H; Kudo T; Shiba D; Shirakawa M; Muratani M; Takahashi S; Aizawa S; Shiga T
    Mol Cell Neurosci; 2022 Jul; 121():103745. PubMed ID: 35660087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model.
    Shibata N; Kawaguchi M; Uchida K; Kakita A; Takahashi H; Nakano R; Fujimura H; Sakoda S; Ihara Y; Nobukuni K; Takehisa Y; Kuroda S; Kokubo Y; Kuzuhara S; Honma T; Mochizuki Y; Mizutani T; Yamada S; Toi S; Sasaki S; Iwata M; Hirano A; Yamamoto T; Kato Y; Sawada T; Kobayashi M
    Neuropathology; 2007 Feb; 27(1):49-61. PubMed ID: 17319283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.
    Lewis KE; Rasmussen AL; Bennett W; King A; West AK; Chung RS; Chuah MI
    J Neuroinflammation; 2014 Mar; 11():55. PubMed ID: 24655927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocytes Support Neuronal Glutamatergic Transmission via Expression of Glutamine Synthetase.
    Xin W; Mironova YA; Shen H; Marino RAM; Waisman A; Lamers WH; Bergles DE; Bonci A
    Cell Rep; 2019 May; 27(8):2262-2271.e5. PubMed ID: 31116973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1(G93A) mutation of familial amyotrophic lateral sclerosis.
    Stieber A; Gonatas JO; Gonatas NK
    J Neurol Sci; 2000 Aug; 177(2):114-23. PubMed ID: 10980307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
    MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
    J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis.
    Chang Q; Martin LJ
    J Neurosci; 2011 Feb; 31(8):2815-27. PubMed ID: 21414903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.
    Fontanilla CV; Gu H; Liu Q; Zhu TZ; Zhou C; Johnstone BH; March KL; Pascuzzi RM; Farlow MR; Du Y
    Sci Rep; 2015 Nov; 5():16953. PubMed ID: 26586020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis's disease-like transgenic (G93A SOD1) mice.
    Zhou Y; Lu Y; Fang X; Zhang J; Li J; Li S; Deng X; Yu Y; Xu R
    Neurodegener Dis; 2015; 15(1):1-12. PubMed ID: 25591625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice.
    Bonfanti E; Bonifacino T; Raffaele S; Milanese M; Morgante E; Bonanno G; Abbracchio MP; Fumagalli M
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
    Kaiser M; Maletzki I; Hülsmann S; Holtmann B; Schulz-Schaeffer W; Kirchhoff F; Bähr M; Neusch C
    J Neurochem; 2006 Nov; 99(3):900-12. PubMed ID: 16925593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis.
    Pehar M; Cassina P; Vargas MR; Castellanos R; Viera L; Beckman JS; Estévez AG; Barbeito L
    J Neurochem; 2004 Apr; 89(2):464-73. PubMed ID: 15056289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis.
    Philips T; Bento-Abreu A; Nonneman A; Haeck W; Staats K; Geelen V; Hersmus N; Küsters B; Van Den Bosch L; Van Damme P; Richardson WD; Robberecht W
    Brain; 2013 Feb; 136(Pt 2):471-82. PubMed ID: 23378219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis.
    Huang G; Lee X; Bian Y; Shao Z; Sheng G; Pepinsky RB; Mi S
    Cell Death Dis; 2013 Oct; 4(10):e841. PubMed ID: 24113175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.